CrossrefInfokarte
Real-World Outcomes Among People Receiving Bictegravir/Emtricitabine/Tenofovir Alafenamide: A Comparison between Those with and without Advanced HIV-1 Disease
Journal of Infection and Public Health · 2026-11 · 103413
DOI: 10.1016/j.jiph.2026.103413 ↗Abstract
Kein Abstract verfügbar.
EUVIMED